Angeion gets CE marking for Sentinel 2010:
This article was originally published in Clinica
Executive Summary
Angeion can affix the CE marking to its Sentinel 2010 implantable cardioverter defibrillator, following review by TUV Product Services, Munich, Germany. The full-function, 60 cc, hot can device weighs 110 grams and is 16 mm thick. Unlike its predecessor the 2000, which was CE-marked in April, the 2010 features stored ECG. Angeion says it should have an active life of up to eight years.
You may also be interested in...
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.